Establishment Labs Ownership

ESTA Stock  USD 43.08  0.47  1.10%   
Establishment Labs holds a total of 28.76 Million outstanding shares. The majority of Establishment Labs Holdings outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Establishment Labs to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Establishment Labs. Please pay attention to any change in the institutional holdings of Establishment Labs Holdings as this could imply that something significant has changed or is about to change at the company. Also note that almost two million eight hundred ten thousand two hundred four invesors are currently shorting Establishment Labs expressing very little confidence in its future performance.
 
Shares in Circulation  
First Issued
2017-03-31
Previous Quarter
27.9 M
Current Value
27.9 M
Avarage Shares Outstanding
22.3 M
Quarterly Volatility
3.9 M
 
Covid
Some institutional investors establish a significant position in stocks such as Establishment Labs in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Establishment Labs, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
As of November 22, 2024, Dividends Paid is expected to decline to about 3.3 M. In addition to that, Dividend Paid And Capex Coverage Ratio is expected to decline to -3.79. As of November 22, 2024, Common Stock Shares Outstanding is expected to decline to about 21.8 M. The current year's Net Loss is expected to grow to about (64.3 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Establishment Stock Ownership Analysis

About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.59. Establishment Labs had not issued any dividends in recent years. Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica. Establishment Labs is traded on NASDAQ Exchange in the United States. To learn more about Establishment Labs Holdings call Juan Quiros at 506 2434 2400 or check out https://www.establishmentlabs.com.
Besides selling stocks to institutional investors, Establishment Labs also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Establishment Labs' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Establishment Labs' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Establishment Labs Quarterly Liabilities And Stockholders Equity

282.69 Million

Establishment Labs Insider Trades History

About 11.0% of Establishment Labs Holdings are currently held by insiders. Unlike Establishment Labs' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Establishment Labs' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Establishment Labs' insider trades
 
Covid

Establishment Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Establishment Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Establishment Labs Holdings backward and forwards among themselves. Establishment Labs' institutional investor refers to the entity that pools money to purchase Establishment Labs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Polar Capital Holdings Plc2024-06-30
546.5 K
Avidity Partners Management Lp2024-06-30
531 K
Boothbay Fund Management, Llc2024-06-30
432 K
Bamco Inc2024-06-30
430.8 K
Sofinnova Ventures2024-06-30
429.2 K
First Turn Management Llc2024-09-30
357 K
Mudita Advisors Llp2024-09-30
354.8 K
Divisadero Street Capital Management, Lp2024-09-30
341.1 K
Affinity Asset Advisors, Llc2024-09-30
290.4 K
Nantahala Capital Management, Llc2024-06-30
M
Jw Asset Management, Llc2024-09-30
3.2 M
Note, although Establishment Labs' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Establishment Labs Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Establishment Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on Establishment Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Establishment Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Lewin Nicholas Sheridan over two months ago
Acquisition by Lewin Nicholas Sheridan of 2345 shares of Establishment Labs subject to Rule 16b-3
 
Caldini Filippo over two months ago
Acquisition by Caldini Filippo of 17910 shares of Establishment Labs at 44.06 subject to Rule 16b-3
 
Filippo Caldini over three months ago
Insider Trading
 
Chacon Quiros Juan Jose over three months ago
Disposition of 3641 shares by Chacon Quiros Juan Jose of Establishment Labs at 45.0396 subject to Rule 16b-3
 
Chacon Quiros Juan Jose over three months ago
Disposition of 654 shares by Chacon Quiros Juan Jose of Establishment Labs at 45.0008 subject to Rule 16b-3
 
Chacon Quiros Juan Jose over three months ago
Disposition of 3866 shares by Chacon Quiros Juan Jose of Establishment Labs at 45.0108 subject to Rule 16b-3
 
Colleran Lisa N over three months ago
Acquisition by Colleran Lisa N of 2345 shares of Establishment Labs subject to Rule 16b-3
 
Schutter Edward J over three months ago
Acquisition by Schutter Edward J of 412 shares of Establishment Labs at 45.44 subject to Rule 16b-3
 
Slotkin Bryan over three months ago
Acquisition by Slotkin Bryan of 296 shares of Establishment Labs at 26.91 subject to Rule 16b-3
 
Gillin Leslie over six months ago
Acquisition by Gillin Leslie of 2334 shares of Establishment Labs subject to Rule 16b-3
 
Custin Ann over six months ago
Acquisition by Custin Ann of 380 shares of Establishment Labs at 50.9 subject to Rule 16b-3
 
Mansbach Samuel Ross over six months ago
Acquisition by Mansbach Samuel Ross of 5406 shares of Establishment Labs subject to Rule 16b-3

Establishment Labs Corporate Filings

14th of November 2024
Other Reports
ViewVerify
13A
12th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
8th of November 2024
Other Reports
ViewVerify
8K
7th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.59)
Revenue Per Share
5.58
Quarterly Revenue Growth
0.045
Return On Assets
(0.12)
Return On Equity
(2.23)
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.